
₨ 55.62

MBBS
Mannitol 20.00% Infusion 500 ml
- Does this requires a prescription ? Yes
- Generic Name: Mannitol, Inf
- Manufactured by : Lahore Chemical & Pharmaceutical works (PVT) LTD
- Drug Strength : 20.00%
- Drug Form : Infusion
- Pack Size : 500 ml
- Product SKU : pg_13858_19318
Mannitol Infusion contains Mannitol, Inf | belongs to Osmotic diuretic
Alternate brands of Mannitol 20.00% Infusion 500 ml
Brand Name | Price | Savings |
---|---|---|
Zeesol-M 20.00% Infusion 1000 ml | ₨ 65.00 | You will pay -9.38 more |
Zeesol-M 20.00% Infusion 500 ml | ₨ 28.21 | You can save 27.41 |
Steriflutol 20.00% Infusion 500 ml | ₨ 124.00 | You will pay -68.38 more |
Medisol-Mannitol 20.00% Infusion 1000 ml | ₨ 84.00 | You will pay -28.38 more |
Medisol-Mannitol 20.00% Infusion 500 ml | ₨ 119.00 | You will pay -63.38 more |
How it works
Mannitol 20.00% Infusion 500 ml is a polyol (sugar alcohol) with a low molecular weight that is filtered at the glomerulus but not reabsorbed from the renal tubule. It exerts osmotic activity within the proximal convoluted tubule and the descending limb of the loop of Henle, which limits passive tubular reabsorption of water.
Side effects
Major & minor side effects for Mannitol 20.00% Infusion 500 ml
- Headache
- Dry mouth
- Dehydration
- Fluid and electrolyte imblance severe
- Chest pain
- Dizziness
- Blurred vision severe
- Nausea
- Fast or irregular heartbeat rare
- Reduced food intake rare
- Uncontrolled shaking of arms or legs rare
- Urinary incontinence rare
Uses of Mannitol 20.00% Infusion 500 ml
What is it prescribed for?
-
Cerebral edema (Fluid accumulation in cerebral cavity)
This medicine is used to reduce cerebral edema (brain swelling) by decreasing the intracranial pressure.
-
Oliguria (Low urine output)
Manilup 20 % Infusion is used to treat oliguria by increasing the urine output.
-
Intraocular pressure (Fluid pressure inside the eye)
This medicine is used to decrease the fluid pressure inside the eye (intraocular pressure).
When not to use?
-
Anuria
This medicine is not recommended for patients with a known history of anuria (a condition where the kidney is unable to produce urine).
-
Severe pulmonary edema (Fluid accumulation in lungs)
This medicine is not recommended for use in patients with a known history of severe pulmonary edema.
-
Progressive heart failure
This medicine is not recommended for use in patients with a known history of progressive heart failure caused by Manilup 20 % Infusion therapy.
-
Intracranial bleeding (Bleeding inside the skull)
Patients with a known history of intracranial bleeding are recommended not to take this medicine.
-
Severe dehydration
This medicine is not recommended for use in patients with severe dehydration.
-
Volume and electrolyte depletion
Manilup 20 % Infusion may alter the blood volume levels and electrolyte levels. This may cause dizziness, dry mouth, and acid-base imbalance. Close monitoring of blood pressure and electrolytes levels is necessary while taking this medicine. Report any symptoms such as weakness, lethargy, muscle pain, drowsiness, dizziness, irregular heartbeat, etc. to the doctor immediately.
-
Allergy
This medicine is not recommended for use in patients with a known allergy to Manilup 20 % Infusion.
-
Crystallization of solutions
This medicine may crystallize when exposed to low temperatures. If crystals are visible, they can be dissolved by warming the solution in a hot water bath or a warming cabinet, followed by gentle agitation (shaking of the vial). Once crystals dissolve, allow the solution to cool to room temperature, reinspect for crystals, and use if crystals are not visible. The medicine should not be used if crystals are present. Please note that the method of warming may differ based on the manufacturer's recommendations.
Dosage
-
Missed Dose
Since this medicine is administered in the clinical/hospital set up by a qualified healthcare professional, the likelihood of a missed dose is very low.
-
Overdose
Since this medicine is administered in the clinical/hospital set up by a qualified healthcare professional, the likelihood of an overdose is very low. However, emergency medical treatment will be provided by the doctor if an overdose is suspected.
General Instructions
Manilup 20 % Infusion will be administered by your doctor or a qualified healthcare professional. Follow all the instructions given by your doctor. Inform the doctor if you have an allergy to this medicine. Report all your current medicines as well as your medical history to the doctor. This medicine is usually given at daytime to prevent sleep disturbance. Drink an adequate amount of water. Monitoring of kidney function and electrolytes levels is necessary during treatment with this medicine. This medicine should be used with caution due to the increased risk of dizziness.
Other details
- Usage does not depend on food timings
- To be taken as instructed by doctor
- Does not cause sleepiness
References
- rxlist.com - Mannitol [Internet]. Available from: https://www.rxlist.com/consumer_mannitol_osmitrol/drugs-condition.htm [cited 7/7/2020].
- sciencedirect.com - Mannitol [Internet]. Available from: https://www.sciencedirect.com/topics/neuroscience/mannitol#:~:text=Mannitol%20is%20a%20polyol%20(sugar,passive%20tubular%20reabsorption%20of%20water. [cited 7/7/2020].
what are the adverse effects of Mannitol 20.00% Infusion 500 ml?
CHF, headache, convulsions, dizziness, rash, electrolyte balance disturbances, hyponatraemia, GI upset, polyurea.
What happens if I miss a dose of Mannitol 20.00% Infusion 500 ml?
Adults: 50-200 gm by IV inf in 24 hr. The rate of administration is usually adjusted to maintain a urine flow of at least 30 to 50 mL per hr.
One of the following licensed pharmacy from the nearest location will deliver Mannitol 20.00% Infusion 500 ml. The details of the licensed pharmacy shall be shared once you request the drugs and the respective pharmacy accepts your request based on valid prescription and availability.
Questions and Answers
There are no questions yet. Be the first to ask a question about this product.
Reviews
There are no reviews yet.